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This study aims to evaluate the effects of diets deficient in choline and/or cystine on hepatocellular injury in animal models (young
male Wistar rats, aged 21 days), by monitoring some of the oxidative stress biomarkers and the expression of RAGE, TNF-𝛼, and
IL-1𝛽. The animals were divided into 6 groups (𝑛 = 10) and submitted to different diets over 30 days: AIN-93 diet (standard, St),
AIN-93 choline deficient (CD) diet and AIN-93 choline and cystine deficient (CCD) diet, in the pellet (pl) and powder (pw) diet
forms. Independently of the diet form, AIN-93 diet already led to hepatic steatosis and CD/CCD diets provoked hepatic damage.
The increase of lipid peroxidation, represented by the evaluation of thiobarbituric acid reactive species, associated with the decrease
of levels of antioxidant enzymes, were the parameters with higher significance toward redox profile in this model of hepatic injury.
Regarding inflammation, in relation to TNF-𝛼, higher levels were evidenced in CD(pl), while, for IL-1𝛽, no significant alteration was
detected. RAGE expression was practically the same in all groups, with exception of CCD(pw) versus CCD(pl). These results together
confirm that AIN-93 causes hepatic steatosis and choline and/or cysteine deficiencies produce important hepatic injury associated
with oxidative stress and inflammatory profiles.
1. Introduction
Hepatic steatosis (HS) is a growing clinical problem world-
wide. It is associated with obesity, insulin resistance (IR),
diabetes mellitus (DM), andmetabolic syndrome (MS) and is
one of the alterations that characterize nonalcoholic fatty liver
disease (NAFLD) [1–4]. The estimated world prevalence of
NAFLD, based on various evaluation methods, ranges from
6.3 to 33% of the population, with an average of 20%. The
main risk factors for the disease are obesity, type 2 diabetes,
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and dyslipidemia. It is estimated that there are at least 1.46
billion obese adults worldwide, from which 6 million people
will progress to nonalcoholic steatohepatitis (NASH) and
some 600,000 to NASH-related cirrhosis [3–7].
Several experimental models have been used to elu-
cidate the mechanisms of NAFLD etiology (histologically
categorized into HS and NASH), particularly using diets
low in the lipotropic factor choline and in methionine [6,
8]. Methionine is an amino acid inserted into the cycle of
choline, cysteine/cystine, and glutathione. Absence or dietary
deficiency of any of these compounds would favor hepatic
triglyceride accumulation, due to defective formation of
very low density lipoproteins (VLDL) and reduced 𝛽-oxida-
tion of lipids. In addition, this deficiency leads to the com-
mittal of the methionine transsulfuration via the diminution
of glutathione levels, thus reducing important part of the
intracellular antioxidant defense [4, 5, 8, 9].
The liver contains a potent enzymatic and nonenzymatic
antioxidant defense system. Liver cells, especially hepato-
cytes, have a substantial capacity to metabolize and effec-
tively detoxify harmful species, such as reactive oxygen and
nitrogen species (ROS/RNS). However, in the presence of
liver injury of any kind, these functions suffer significant
drawbacks [10].
Oxidative stress (OS), which reflects an imbalance
between prooxidants and antioxidants with increased reac-
tive oxygen species (ROS) and/or decrease of antioxidants,
is characteristic of several diseases (acute or chronic) that
affect the liver. It includes induction of inflammatory process
viaKupffer and Ito cells activation, monocytes, macrophages,
and dendritic cells as well as natural killer cell recruitment.
In this step, these cells recruited in response to injury
emit proinflammatory signals including cytokines (TNF-𝛼,
IL-6, and IL-1), chemokines, lipid messengers, and ROS.
This results in a moderate self-limiting inflammation or
advancement of apoptosis or necrosis, which aggravates the
inflammatory response and may lead to fibrosis [11–13].
Another pathway of inducing OS and liver inflamma-
tion occurs through the production of advanced glycation
end products (AGEs). AGEs are a heterogeneous group
of molecules produced by in vivo glycation and oxidation
that modify chemical and biological properties of several
molecules [14, 15]. AGEs are also formed exogenously by
heating foods at high temperature and low humidity and
could enhance, together with endogenous AGE, the danger-
ous action into the body [16]. Depending on the cell type
and experimental conditions, AGEs interaction with their
receptors, RAGE, in hepatocytes and hepatic stellate cells
leads to an increased production of ROS through activation
of nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase. This enhances cell proliferation and activation, thus
playing a role in the progression of hepatic fibrosis to NASH
[14, 17, 18].
There are many questions regarding the pathophysiolog-
ical mechanism of liver diseases. A variety of dietary treat-
ments can be used to induce liver damage; however themodel
of lipotropic factors deficient diets induces a more aggres-
sive damage with the rapid progress toward NASH [6, 8]. In
this study, AIN-93G (growth) diet as a standard diet and the
Table 1: AIN-93 formulation according to selected groups.
Group Diet formulation
Standard St(pw)/St(pl) AIN-93
Choline deficient
CD(pw)/CD(pl)
AIN-93 deficient in choline:
powder (pw) or pellet (pl)
Choline and cystine
Deficient CCD(pw)/CD(pl)
AIN-93 deficient in choline and
cystine: powder (pw) or pellet
(pl)
experimental models of NAFLD were chosen, according to
REEVES [19]. This formulation has casein as the standard
protein and cystine and choline as adding factors. The
experimental models, compared to the standard (St) diet are
based on the nonaddition of these lipotropic dietary factors.
Along this line, the present paper aims to evaluate the
effects of diets deficient in choline and for the first time, in
choline-cystine, on hepatocellular injury in animal models
by monitoring some of the OS biomarkers such as pro-
tein carbonylation and TBARS, related to oxidative dam-
age, enzymatic antioxidant defense, characterized by cata-
lase (CAT) and superoxide dismutase (SOD) activities, and
nonenzymatic defense, represented by total thiols. In addi-
tion, the presence of inflammation through RAGE, TNF-𝛼,
and IL-1𝛽 expression was evaluated.
2. Material and Methods
2.1. Animals and Chemicals. MaleWistar rats (30–35 g, aged
21 days) were obtained from the laboratory animal house at
the Federal University of Alagoas (UFAL), Maceio, Alagoas,
Brazil. The animals were kept in individual metabolic cages
in the experimental laboratory animal house of the School of
Nutrition, UFAL. The animals had free access to water and
food and were maintained in a 12 h light-dark cycle (lights
on at 7 AM), under controlled temperature (20–24∘C).These
conditions were kept constant throughout the experiments.
All experimental procedures were performed in accordance
with the National Institute of Health Guide for the Care
and Use of Laboratory Animals and the Brazilian Society for
Neuroscience andBehavior Recommendations for Animal Care
(006549/2011-10). All chemicals were purchased from Sigma
Aldrich (St. Louis, Missouri).
2.2. Protocol. The animals were divided into 6 groups (𝑛 =
10) (Table 1) and submitted to different diets during 30
days. Diets were formulated from a food composition of the
American Institute of Nutrition (AIN, version 93) [19] with
inducers of NAFLD in the form of pellets(pl) and powder(pw):
a standard (St) (AIN-93 in its original composition), CD
(AIN-93 deficient in choline), and CCD (AIN-93 deficient in
choline and cystine).
The contents of the original sucrose diet (10%) were
replaced by corn starch. The diets were provided by
RHOSTER Industry and Commerce Ltd. (Sa˜o Paulo, Brazil).
The bodymass and food intake of the animals weremeasured
weekly.
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At the end of experimental period, after fast of 12 hours,
the animals were anesthetized (ketamine, 100mg/kg, and
xylazine, 15mg/kg, via intraperitoneal injection in the right
inferior quadrant of rat) and euthanized by sectioning off
the aorta. Blood was collected and the plasma separated
for subsequent biochemical analysis: fasting glucose, lipid
profile, and liver function and injury.The liver was dissected,
placed on liquid nitrogen, and immediately stored at −80∘C
for later analysis. Immediately before the analysis, the organs
were homogenized in PBS 10mM with Potter-Elvehjem
apparatus and centrifuged (10000 g, 10min at 4∘C) to remove
cellular debris. Supernatants were used for all stress oxidative
biochemical assays. Protein (ptn) content was quantified
using the Lowry protein assay [20].
2.3. Histological Analysis. After fixation with 10% buffered
formalin, the organs were cleaved and the sections were
processed by embedding in paraffin and stained with hema-
toxylin and eosin. Macroscopic alterations of the organs were
recorded whenever present. Histopathological evaluation to
determine hepatocellular damagewas based on the guidelines
of “The Diagnosis and Management of Non-Alcoholic Fatty
Liver Disease: Practice Guideline by the American Gastro-
enterological Association, American Association for the
Study of Liver Diseases, and the American College of Gas-
troenterology” [3].
2.4. Oxidative Damage
2.4.1. Thiobarbituric Acid Reactive Species. TBARS (thiobar-
bituric acid reactive species) iswidely adopted as amethod for
measurement of the lipid redox state [21]. Briefly, the samples
were mixed with 0.6mL of 10% trichloroacetic acid (TCA)
and 0.5mL of 0.67% thiobarbituric acid and then heated
in a boiling water bath for 25min. TBARS was determined
by spectrophotometry at 532 nm. TBARS concentration in
the samples was obtained from a calibration curve that was
prepared using 1,1,3,3-tetramethoxypropane (TMP) as the
standard, which was subjected to the same treatment as
that applied to the supernatants of the samples. Results are
expressed as nmol TBARS/mg protein.
2.4.2. Carbonylated Proteins. Oxidative protein damage was
measured by the quantification of carbonyl groups based
on their reaction with 2,4-dinitrophenylhydrazine (DNPH).
Proteins were precipitated by the addition of 20% TCA and
resuspended in 10mM DNPH and the absorbance read at
370 nm [22]. Results were expressed as nmol carbonyl/mg
protein.
2.5. Antioxidant Enzymes. Catalase (CAT) activity [23] was
measured as described in the literature [24]. The rate of
decrease in absorbance at 240 nm was used as an index of
H2O2 degradation by catalase. One unit of CAT was consid-
ered the amount of enzyme needed to degrade 1mmol/min
H2O2 at 25
∘C. Superoxide dismutase (SOD) activity was
assessed by quantifying the inhibition of superoxide depen-
dent epinephrine autooxidation in a spectrophotometer at
480 nm [25].The assaywas carried out in 96-wellmicroplates,
using a Thermo Scientific UV-Vis microplate spectropho-
tometer.
2.6. Nonenzymatic Antioxidants
2.6.1. Total Reduced Thiol Content. To quantify the content
of reduced thiols, samples were diluted in 10mM phosphate
buffer (pH 7.4), followed by the addition of 5,5󸀠-dithiobis(2-
nitrobenzoic acid) (DTNB) (0.01M), in ethanol. An intense
yellow color was developed and read at 412 nm after 20min.
A blank control was run simultaneously, without addition of
DTNB. Protein thiol content was calculated after subtraction
of the blank absorbance, utilizing the molar extinction
coefficient of 13 600M/cm [26].
2.7. Analysis ofWesternBlot for RAGE, IL-1𝛽, andTNF-𝛼 in the
Hepatic Tissue. To perform immunoblot experiments, liver
tissue samples were homogenized in Laemmli sample buffer
(62.5mM Tris-HCl, pH 6.8, 1% (w/v) SDS, and 10% (v/v)
glycerol) and then equal amounts of the protein homogenate
(40 𝜇g/well) were fractionated, quantified by SDS-PAGE,
and electroblotted onto nitrocellulose membranes. Protein
loading and electroblotting efficiency were verified through
Ponceau S staining, and the membrane was blocked with
Tween Tris buffered saline (TTBS: 100mM Tris-HCl, pH
7.5, 0.9% NaCl, and 0.1% Tween-20) containing 5% albumin.
Membranes were incubated overnight at 4∘C with each anti-
body separately in TTBS and at different working dilutions, as
suggested by themanufacturers, and thenwashedwith TTBS.
Anti-rabbit IgG peroxidase linked with a secondary antibody
was incubated with the membranes for an additional 1 h
(1 : 5,000 dilution range), it was washed again, and the
immunoreactivity detected by enhanced chemiluminescence.
Thereafter, the membranes were incubated for 12 h with anti-
rabbit primary from Sigma Aldrich (anti-IL1𝛽 and anti-
TNF-𝛼, ABCAM; anti-RAGE (N-terminal)) (1 : 1,000, anti-
𝛽-actin dilution range, Cell Signaling) and then washed
again and the immunoreactivity was detected by enhanced
chemiluminescence. Densitometric analysis was carried out
with ImageJ software. All results were expressed as a ratio
relative to the 𝛽-actin internal control.
2.8. Statistical Analysis. Results were shown as mean ±
standard error (SEM) for each group. Statistical analysis was
performedusingGraphPadPrism. Formultiple comparisons,
one-way analysis of variance (ANOVA) was used. In the case
of ANOVA, the results showed significant differences. Post
hoc analysis was performed with Tukey’s test. 𝑝 < 0.05 was
considered to be statistically significant.
3. Results
3.1. Analysis of Body Weight and Absolute and Relative
Liver Weights. The parameters of food intake, weight gain,
body weight end, liver weight, and relative liver showed no
statistical difference (𝑝 ≥ 0.05) (Table 2).
3.2. AIN-93 Diet (Pellets and Powder) and Its Influence on
Hepatic Steatosis. Animals fed with AIN-93 diet for 30 days
(Stpw/pl) showed hepatocellular damage, independently of the
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Table 2: Food intake, weight gain, end weight of body, liver weight, and relative liver weight for the different dietary models (mean ± SEM).
Standard: St; CD: deficient in choline; CCD: deficient in choline and cystine; pl: pellet; pw: powder.
St(pw) St(pl) CD(pw) CD(pl) CCD(pw) CCD(pl)
Food intake (g) 102.70 ± 5.00a 104.00 ± 5.24a 97.51 ± 5.07a 101.80 ± 5.31a 103.70 ± 4.319a 100.30 ± 5.60a
Weight gain (g) 145.20 ± 3.55a 157.50 ± 5.53a 145.90 ± 7.29a 154.80 ± 5.90a 143.70 ± 4.40a 155.2 ± 6.87a
End weight of body (g) 176.80 ± 3.59a 190.00 ± 5.85a 177.10 ± 7.54a 185.90 ± 5.69a 175.90 ± 5.34a 188.30 ± 7.73a
Liver weight (g) 7.39 ± 0.31a 7.65 ± 0.33a 7.46 ± 0.31a 7.65 ± 0.28a 7.42 ± 0.22a 7.55 ± 0.30a
Relative liver weight 0.04 ± 0.00a 0.04 ± 0.00a 0.04 ± 0.00a 0.04 ± 0.00a 0.04 ± 0.00a 0.04 ± 0.00a
aMeans similarity with other a, in terms of statistics. Different letters indicate 𝑝 < 0.05 (Tukey test).
absence of lipotropic factors and the diet presentation (pw
or pl). The standard (St) group had mild HS, with disorga-
nized hepatocyte cords next to the periportal zone (Figures
1(a) and 1(b)). On the other hand, the CD group showed
intense HS, independently of the zone, with disorganized
hepatocyte cords throughout the hepatic tissue, ballooning of
hepatocytes, few inflammatory infiltrates, and cellular death
(Figures 1(c) and 1(d)). In the CCD group, disorganized
hepatocyte cords similar to the CD group were found, as
well as microvesicular steatosis, an increase in the size of
nucleus or its death in hepatocytes, Mallory corpuscles, and
cellular death, while hepatocyte ballooning or inflammatory
infiltrates (Figures 1(e) and 1(f)) were not found.
3.3. Analysis of Redox Profile. Regarding nonenzymatic anal-
yses, in relation to TBARS, the St(pw/pl) groups showed the
same TBARS levels as the CD(pw) group and lower than
CD(pl) and CCD(pw/pl) groups (𝑝 < 0.05). CD(pl) and
CCD(pw/pl) groups were statistically similar (𝑝 ≥ 0.05).
Toward carbonylated protein the CD(pw) group showed lower
levels than the CCD(pw/pl) group (𝑝 < 0.05).The other groups
were statistically similar (𝑝 ≥ 0.05).
In the evaluation of antioxidant enzymes, hepatic SOD
andCAT activities were lower in theCD(pw/pl) andCCD(pw/pl)
animals compared to the St(pw/pl) (𝑝 < 0.05). In relation to
nonenzymatic antioxidants, glutathione and other thiols were
measured as total thiols. All groups fedwithAIN-93 diet were
statistically similar (𝑝 ≥ 0.05) (Figure 2).
3.4. Analysis of RAGE, TNF-𝛼, and IL-1𝛽 Expression. In
this study, RAGE expression by immunoblot detection was
highest in the CDD(pw) group compared to CCD(pl) (𝑝 <
0.05) groups and similar to other groups, all of which were
statistically similar (𝑝 ≥ 0.05) (Figure 3(a)). In respect to
TNF-𝛼 (Figure 3(b)), its expression was higher in the CD(pl)
group than the other groups (𝑝 < 0.05), except for the St(pw)
group (𝑝 ≥ 0.05). The CCD(pl) group had the lowest levels of
TNF-𝛼 (𝑃 < 0.001) between the experimental groups, except
the St(pw) group, which was statistically similar (𝑝 ≥ 0.05). In
respect to IL-1𝛽 expression (Figure 3(d)), all groups fed with
AIN-93 diet were statistically similar (𝑝 ≥ 0.05).
4. Discussion
Diets deficient in choline are related with HS development
[27]. Choline is a water soluble essential nutrient (quaternary
ammonium salt). Choline and its metabolites are needed
for three main physiological purposes: structural integrity
and signaling roles for cell membranes, cholinergic neuro-
transmission (acetylcholine synthesis), and being a major
source for methyl groups via its metabolite, trimethylglycine
(betaine), which participates in the S-adenosylmethionine
(SAMe) synthesis pathways [28, 29]. As reported, choline
presents several functions in the body; however it is mostly
phosphorylated and used as part of membrane phospholipids
or oxidized such as methyl group donor [30]. Thus, when a
choline deficiency occurs, the VLDL synthesis is impaired,
once this lipoprotein needs phosphatidylcholine in its struc-
ture.
Additionally, choline is part of mitochondrial membrane
and its deficiency causes alterations in this organelle and
consequently leads to NAFLD. It is believed that complex I
is one of the major sources of ROS in liver mitochondria and,
in case of choline deficiency, the liver mitochondria compo-
sition is significantly altered. This could be associated with
changes in respiratory chain complex I activity, calledNADH:
ubiquinone oxidoreductase and this could be modulated in
rats fed with choline deficient diet [30, 31].
Recently, the scientific community recommended the use
of choline deficient (CD) diet, on an exclusive basis. These
formulations cause NASH, but the worsening of this disease
is prolonged when compared to alteration caused by a diet
deficient in both choline and methionine (CMD). Addition-
ally, CMD can promote hepatic fibrosis and hepatocellular
carcinoma (HCC) [32]. Although CMD was shown to cause
a more intense hepatic injury, this food restriction presents
some limitations. It was reported that rats fed with CMD diet
had weight loss up to 35% in 4 weeks. It was also shown
that depending on the rodent species, the NAFLD induced
by CMD varies considerably [27].
As an example, Vetela¨inen and coworkers [33] identified
weight loss, severe steatosis, increased OS (evaluated by
TBARS and reduced glutathione levels), decreased antioxi-
dant capacity, and NASH progression (inflammation medi-
ated by KC and fibrogenesis) in animals that received CMD
diet for 7 weeks [33]. In contrast, mice fed with the CD
diet developed uncomplicated steatosis or a profile similar
to the human metabolic syndrome (MS), such as insulin
resistance (IR), dyslipidemia, and obesity. These models
represent two different NAFLD pathogenic forms. In our
study, the dietmodel chosenwasAIN-93M (maintenance), in
which the amino acid of addition is cystinewhose precursor is
methionine. It is believed that L-cysteine has a sparing effect
on methionine, in reducing the catabolism of methionine
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Standard (St) St
200x
300x
Choline deficient (CD) CD
200x
400x
Choline and cystine
deficient (CCD)
CCD
200x 300x
(1a)
(2a)
(3a)
(1b)
(2b)
(3b)
Figure 1: Representative photomicrographs of hematoxylin and eosin staining of liver sections. St (1a) (200x): arrow indicating periportal
zone with disorganized hepatocyte cords; St (1b) (300x): hepatic steatosis, arrow indicating fat accumulation in hepatic intracellular vacuole;
CD (2a) (200x): arrow indicating hepatic cord disorganisation around centrilobular zone, hepatic steatosis, and signals suggestive of fibrosis;
CD (2b) (400x): arrows indicating ballooning degeneration of hepatocytes and macro and microvesicular steatosis; CCD (3a) (200x): arrow
indicating hepatic cord disorganisation, nucleus with increased size, and microvesicular steatosis; St (3b) (300x): right arrow indicating
nucleus with increased size and arrow nuclear breakdown, Mallory corpuscles.
through a transsulfuration pathway [9]. Thus, via cystine
deficient diet, methionine present in casein will be used
to restore cysteine levels, causing combined deficiency of
synthesis of other compounds methionine dependents, such
as choline and GSH, and together those alterations are
able to cause hepatic injury and oxidative stress. Thus, the
results were similar to the ones earlier obtained [33], with
increased hepatocellular damage and OS being identified in
animals receiving a diet deficient in both lipotropic factors
(CCD). As such, our model (Table 1) allowed the evaluation
of NAFLD progression, as well as differences and similarities
in the quantification of OS at different moments in the
pathophysiological process.
However, for final bodyweight, absolute, and relative liver
weight (Table 2), no significant differences were observed, as
well as serum biochemistry (data not shown). Our hypothesis
was that the experimental time was not enough for the
development of such changes.
Another fact that deserves attention in this study was
that animals fed with AIN-93 standard (St) diet showed
mild hepatocellular damage (HS). This fact had already been
identified in previous studies in different contexts [34–37],
suggesting that the AIN-93 composition is inappropriate and
justifying, therefore, our option for the present diet (Table 1),
and which, independent of changes in diet composition, led
to HS. One hypothesis to explain this liver damage is related
to inadequate amounts of choline and sulfur-containing
amino acids in the diet.
In respect to evaluation of oxidative damage, it has been
known that carbonyl groups quantification is largely used as
a marker of oxidative damage in proteins [38]. In our study,
we found significant differences in the carbonylated protein
analysis only between DCC(pw) and DC(pw) groups, with
high levels of carbonyl in severe liver damage group. Besides
protein damage, the membrane injury caused by lipid perox-
idation (LP) is also an oxidative stress consequence [11]. In
this context, it was observed that the St(pw/pl) groups showed
a lower TBARS level than CD(pl) and CCD(pw/pl) groups
(𝑝 < 0.05). LP causes direct damage to cell membranes
(and organelles), generates intermediates which can serve as a
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Figure 2: TBARS (a), carbonylated protein (b), thiols group (SH) (c), catalase (d), and SOD (e) in liver tissue for the different dietary models
(mean ± SEM). Standard (St); CD: deficient in choline; CCD: deficient in choline and cystine; pl: pellet; pw: powder. Different letters indicate
𝑝 < 0.05 (Tukey test).
substrate for the synthesis of toxic compounds to the environ-
ment, and still produces intermediate metabolites involved
in the carbonylation reaction [4]. Protein carbonylation may
have contributed to the reduction in circulating levels of
protein. According to several authors, modified proteins cell
death persists if oxidized proteins are not removed by the
proteasome [39, 40].
Simultaneously with lipid accumulation in liver, an alter-
ation in electron transport chain can occur, causing an
increase of ROS production, in terms of anion radical super-
oxide (O2
∙−) and hydrogen peroxide (H2O2). These species
can oxidize polyunsaturated fatty acids (PUFAs) present
in cell and organelle membranes leading to several events
and producing LP metabolites like malondialdehyde (MDA)
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Figure 3: Western blot analysis of RAGE, IL-1𝛽, and TNF-𝛼 (𝛽-actin internal control) (a). Mean ± SE Protein content of RAGE (b), IL-1𝛽
(c), and TNF-𝛼 (d) in rat livers for different dietary models (mean ± SEM); Standard (St); CD: deficient in choline; CCD: deficient in choline
and cystine; pl: pellet; pw: powder. ∗𝑝 < 0.05; ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001 (Tukey test).
and 4-hydroxynonenal (4-HNE) [41]. Moreover, the LP of
PUFAs inmitochondrial membrane has been associated with
apolipoprotein B (ApoB) proteolysis, and this reduces VLDL
secretion in rodents, promoting triacylglycerol accumulation
in liver [1] and causing severe morphofunctional alterations
in both deficient diet groups in this study.
LP metabolites cause alteration in both deoxyribonu-
cleic acid (DNA) and protein synthesis, decrease GSH lev-
els, increase proinflammatory cytokines synthesis, promote
influx of inflammatory cells into liver, and activate Ito cells,
causing collagen deposition, hepatic fibrosis, hepatocytes
death, and necrosis, all of which being histological charac-
teristics of NAFDL evaluation [1, 42].
The antioxidant defense provided by thiols, like glu-
tathione complex, shows no significant difference between
groups, regardless of the presence of HS or severe hepato-
cellular damage, unlike the results found for CAT and SOD,
whose activity levels decreased with the severity of liver
damage. In the study by Bakala et al. [43], it was suggested
that the redox cycle of glutathione was the largest source of
protection in the presence of low levels of hydrogen peroxide,
whereas CAT becomes more significant in cytoprotection,
in severe OS, when glutathione concentration had already
been depleted [43]. This fact can be explained both by
protein carbonylation which decreases the activity of the
sulfur components with antioxidant functions and by the
dietary model used, since the reduction of lipotropic factors
contributes to decrease of glutathione synthesis [44, 45].
Elevated levels of carbonylated proteins also contribute to a
reduction in SODactivity, since intermediarymetabolites like
methylglyoxal react with lysine and arginine, components of
this enzyme, and as a result there is an elevation in the levels
of superoxide anion and inhibition of CAT activity [46].
OS is closely related to the inflammatory process, a
condition observed in many diseases such as cardiovascular
disease (CVD) [47–50], cancer [51–53], and gastrointestinal
diseases [3, 54, 55]. Several markers had been used to verify
inflammatory activity in vivo. Currently, in the scientific
literature, there is emphasis on identifying RAGE expression,
once this receptor has the ability to recognizemultiple ligands
and therefore can participate in pathophysiological events
related primarily to the propagation of cell dysfunction [15,
56] and increased the synthesis of various interleukins, such
as IL-6 and IL-1𝛽 [57–60].
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Choline/choline + cystine deficient
HC
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NASH
and oxidative stress
AGEs
Hepatocellular injury
balloonized hepatocytes
with or without fibrosis
Lipid peroxidation
Hepatic
amino acid
Glyoxal
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AGEs/RAGE
Carbonylated
proteins
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↓ Glutathione
↑ TNF-𝛼, IL-1𝛽
↑ Inflammation
Figure 4:Diets deficient in choline (CD) or choline and cystine (CCD) decrease the formation of hepaticVLDL and antioxidants derived from
thiols (for instance, glutathione), leading to hepatic steatosis (HS) and increased susceptibility to oxidative stress (OS).HS leads toOS and lipid
peroxidation (LP) (directly); additionally, OS also stimulates the production of inflammatory cytokines. LP leads to the formation of reactive
intermediates (glyoxal and methylglyoxal) which by interacting with proteins (amino acids) cause liver tissue modifications: carbonylation
of proteins including enzymatic antioxidants (SOD, CAT, and SH) and formation of AGEs. AGEs can interact with cell receptors, RAGE,
triggering a cascade reaction that increases inflammation and intracellular OS. Additionally, inflammatory cytokines increased directly by
OS also contribute to the reaction described above, resulting in hepatocellular injury, hepatocyte ballooning with or without fibrosis, leading
to NASH and eventually to hepatocellular carcinoma (HC).
The lower expression of RAGE in CCD(pl) compared to
CDD(pw) group may indicate a decrease of inflammatory
activity in the animals fed with deficient diet pellets group.
Similar data were observed for TNF-𝛼 expression. It has
suggested that the advance of liver damage in this group,
demonstrated by histology, has contributed to the exhaustion
of these inflammatory markers in this tissue.
It was emphasized, in our study, that HS was present
in all standard groups and in the one deficient in choline,
regardless of the form of the diet, if in powder or in pellets. In
addition, an important fact demonstrated by the analysis of
inflammatory markers was that the intensity of steatosis was
not able to change the RAGE expression between the groups,
demonstrating that inflammation may be present from the
mild fat accumulation. An overall picture of our results is
shown in Figure 4 (Figure 4).
In the study by Gaens and coworkers [61], which evalu-
ated liver biopsies and serum samples from obese individ-
uals, the authors observed that the immune-histochemical
staining of RAGE in biopsies was specifically and exclusively
located in the membrane of hepatocytes with steatosis,
whereas hepatocytes without steatosis did not show staining
for RAGE. Also according to these authors, lipid accumula-
tion in hepatocytes (in vitro) was associated with increased
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expression of RAGE, plasminogen activator inhibitor-1 (PAI-
1), interleukin 8 (IL-8), interleukin 6 (IL-6), and C-reactive
protein (CRP), all related to the inflammatory process
[61].
The study by Leung and coworkers [62] compared the
expression of RAGE in three groups of animals fed with diets
in pelletized form: one fed with a standard diet, another with
a CMD (cysteine/methionine deficient) diet, and finally a
group that was fed with a CMD diet prepared with additional
heating. One of the results observed was an increase in these
receptors (RAGE) in the third group, most likely due to the
higher amount of exogenous AGEs ingested [62].
RAGE activation has been implicated in inflammation
as well as in cancer, diabetes, and Alzheimer’s disease [63].
Strong upregulation of RAGE and its ligands were found
in different tumors and experimental evidence supports a
critical role for RAGE and its ligands in tumorigenesis and
metastasis, by still unknownmechanisms [63, 64]. Pusterla et
al. [65], studying RAGE expression in oval cell from liver by
two models: a genetic model of Mdr2−/− RAGE−/− double
knockout mice and a pharmacologic blockade of RAGE
model, found that RAGE ablation does not affect inflam-
matory cell recruitment; however the authors identified a
novel function of RAGE in regulating oval cell activation
and tumor development in inflammation-associated liver
carcinogenesis [65]. Confirming these findings, Ito et al. [66],
studying the expression of RAGE in hepatectomized patients,
verified that the higher the expression of these receptors
was, the worse the therapeutic outcome of these patients was
(lower survival and further development of hepatocellular
carcinoma) and, therefore, future therapeutic approaches
aimed at the blocking of RAGE need to be tested [66].
Activation of RAGEs has as consequence, the stimulation
of nuclear factor kappa B (NF-𝜅B) that increases the produc-
tion of various proinflammatory substances, among them IL-
1𝛽 and TNF-𝛼 [67]. In our study, IL-1𝛽, involved in hepatic
lipid accumulation, cellular death, and fibrogenesis [57, 58],
did not differ between groups.
The pathogenesis of NASH involves several steps includ-
ing lipotoxicity, intestinal endotoxins, and innate immune
responses such as toll-like receptors (TLRs), proinflam-
matory cytokines, and OS in the endoplasmic reticulum.
Inflammatory cytokines such as TNF-𝛼, IL-6, and IL-1may be
produced by Kupffer cells, which also contribute to increased
hepatic injury through complement factor synthesis and ROS
[57–59].
TNF-𝛼 contributes to inflammation, IR, andHS, bymod-
ulating SREBP-f (sterol regulatory element-binding protein)
activity. TNF-𝛼may be produced by other cells besides KCs,
such as adipose tissue cells and hepatocytes [4]. This factor
contributes significantly to cellular dysfunction by promoting
the production of ROS/RNS by causing a dysfunction in
the electron transport chain, inducing cell death through
the activation of caspase-8 and the apoptotic cascade in the
cytosol [59].
Despite the conflicting results of this study for TNF-𝛼, a
growing body of evidence supports a central role of TNF-𝛼
and other inflammatory cytokines in the progression ofHS to
NASH, with a correlation between circulating levels of these
cytokines and the severity of steatosis, necroinflammation
and fibrosis [59].
5. Conclusions
The CD/CCD diets were sufficient to provoke liver damage,
regardless of the form (powder or pellets) they were given in,
allowing the differentiation or discrimination of the various
evolutionary stages of NAFLD. Moreover, for all the models
studied, the powder or pellet forms did not lead to significant
differences in any of the evaluated parameters. Another
important fact was the presence of HS in rats fed with the
AIN-93 diet in its standard formulation, demonstrating that
this food, for this study, was unsuitable for animal feed.
Another noteworthy point was the study of the antioxidant
compounds, where the thiol groups represented the first
system of defense to be consumed, with a reduction in their
levels frommild hepatocellular damage, unlike the enzymatic
compounds evaluated.
Regards to inflammation, TNF-𝛼 revealed a synchronic-
ity with the data for RAGE and both of these with the redox
imbalance data.
However, further studies are necessary for a better under-
standing of the advanced stages of the disease, as well as the
expression of inflammation markers.
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